Stock Events

Stock Events

Pulse Biosciences 

€17.6
0
+€0.1+0.57% Monday 06:03

Statistics

Day High
17.6
Day Low
17.6
52W High
21.4
52W Low
11.1
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12AugExpected
Q4 2025
Q1 2026
Next
-0.23
-0.21
-0.18
-0.16
Expected EPS
-0.23468225
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 6L8.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Boston Scientific
BSX
Mkt Cap83.97B
Boston Scientific Corporation offers a wide range of medical devices that compete in the cardiovascular and neuromodulation markets, overlapping with Pulse Biosciences' therapeutic areas.
Medtronic
MDT
Mkt Cap102.71B
Medtronic is a global leader in medical technology, services, and solutions, competing across several of Pulse Biosciences' key areas, including cardiac and vascular therapies.
Intuitive Surgical
ISRG
Mkt Cap162.13B
Intuitive Surgical, known for its da Vinci surgical systems, competes with Pulse Biosciences in the field of minimally invasive surgery, albeit through different technological approaches.
Stryker
SYK
Mkt Cap112.88B
Stryker is a medical technologies firm that competes with Pulse Biosciences in the development of surgical and neurotechnology products.
Zimmer Biomet
ZBH
Mkt Cap16.05B
Zimmer Biomet Holdings, Inc. competes in the musculoskeletal healthcare sector, offering products that can be seen as alternatives to Pulse Biosciences' treatments.
Edwards Lifesciences
EW
Mkt Cap48.42B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, competing with Pulse Biosciences in the broader field of medical devices for cardiovascular health.
Hologic
HOLX
Mkt Cap16.97B
Hologic, Inc. focuses on diagnostics, medical imaging systems, and surgical products for women's health, competing with Pulse Biosciences in the medical device market.
Baxter International
BAX
Mkt Cap8.88B
Baxter International Inc. provides a broad portfolio of renal and hospital products, including bio-surgery products that compete with Pulse Biosciences' offerings in the surgical market.

About

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
Show more...
CEO
Mr. Paul Arthur LaViolette M.B.A.
Employees
116
Country
United States
ISIN
US74587B1017

Listings

MU
DE
6L8.MU
STU
DE
6L8.STU
F
DE
6L8.F
XNAS
US
PLSE

0 Comments

Share your thoughts

FAQ

What is Pulse Biosciences stock price today?▼
The current price of 6L8.MU is €17.6 EUR — it has increased by +0.57% in the past 24 hours. Watch Pulse Biosciences stock price performance more closely on the chart.
What is Pulse Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Pulse Biosciences stocks are traded under the ticker 6L8.MU.
When is the next Pulse Biosciences earnings date?▼
Pulse Biosciences is going to release the next earnings report on August 12, 2026.
What were Pulse Biosciences earnings last quarter?▼
6L8.MU earnings for the last quarter are -0.2 EUR per share, whereas the estimation was -0.23 EUR resulting in a +11.8% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Pulse Biosciences have?▼
As of May 06, 2026, the company has 116 employees.
In which sector is Pulse Biosciences located?▼
Pulse Biosciences operates in the Health & Wellness sector.
When did Pulse Biosciences complete a stock split?▼
Pulse Biosciences has not had any recent stock splits.
Where is Pulse Biosciences headquartered?▼
Pulse Biosciences is headquartered in Miami, United States.